Recently, Wang et al. [70] demonstrate that NASH is accompanied by an expansion of activated NK cells characterized by high expression of the killer activating receptor NKG2D, granzyme B and INF-γ. The gene discussed is KLRK1; the disease is metabolic dysfunction-associated steatohepatitis.